Robotic-assisted laparoscopic radical prostatectomy (RALP) has enjoyed rapid adoption over the past decade without rigorous clinical studies demonstrating superior clinical outcomes over radical retropubic prostatectomy (RRP).
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
This article reviews the literature comparing RALP and RRP with regard to oncologic, perioperative, and functional outcomes, summarizing evidence for and against the superiority of RALP.
Eifler JB, Cookson MS. Are you the author?
Department of Urologic Surgery, Vanderbilt University Medical Center, A1302/Medical Center North, 1161 21st Avenue, South, Nashville, TN 37232, USA; Department of Urology, University of Oklahoma College of Medicine, 920 Stanton L. Young Boulevard, Oklahoma City, OK 73104, USA.
Reference: Urol Clin North Am. 2014 Nov;41(4):493-502.